The blood-brain barrier border protects the brain by regulating the flow of molecules, peptides, and cells, but it also keeps out many therapeutics. Now, researchers have harnessed the power of a ...

Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical trial of the vaccine candidate ALZ-101 in early Alzheimer's disease. This mi ...

A team of scientists, including researchers from University College London (UCL), has discovered key differences in how four ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern University reports that NU-9, an experimental small-molecule drug currently ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (A?) monoclonal antibody Leqembi® ...

The Cloud Streaming Beta is currently available to PlayStation Plus Premium members, and allows them to play select PS5 games from the PS Plus Catalog through cloud streaming on the PS Portal.

Navigating the Risk-Benefit Conversation: Discussing Amyloid-Targeting Therapies With Patients and Caregivers EP: 13 . Criteria for Discontinuing Treatment With an Amyloid-Targeting Therapy ...

That’s right: we’re talking about beta blockers. But, if it feels like beta blockers are becoming A Thing all of sudden, keep in mind that it might just be reflective of a cultural shift about ...

Read our privacy notice. Generation names are becoming increasingly confusing, with the latest cohort, Generation Beta, born from this year, and "zillennials" now emerging as a subgeneration ...